Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.

CompletedOBSERVATIONAL

Enrollment

210

Participants

Timeline

Start Date

December 1, 2013

Primary Completion Date

December 1, 2013

Study Completion Date

June 30, 2015

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG

Gemcitabine - nabpaclitaxel

efficacy and safety

All Listed Sponsors

lead

Galician Research Group on Digestive Tumors

OTHER

NCT03620461 - Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma. | Biotech Hunter | Biotech Hunter